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Background. Previous evidence on factors and causes of readmissions associated with high-impact users of stroke is scanty.The aim
of the study was to investigate common causes and pattern of short- and long-term readmissions stroke patients by conducting a
systematic review of studies using hospital administrative data. Common risk factors associated with the change of readmission
rate were also examined.Methods. The literature search was conducted from 15 February to 15 March 2016 using various databases,
such as Medline, Embase, and Web of Science. Results. There were a total of 24 studies (𝑛 = 2,126,617) included in the review.
Only 4 studies assessed causes of readmissions in stroke patients with the follow-up duration from 30 days to 5 years. Common
causes of readmissions inmajority of the studies were recurrent stroke, infections, and cardiac conditions. Common patient-related
risk factors associated with increased readmission rate were age and history of coronary heart disease, heart failure, renal disease,
respiratory disease, peripheral arterial disease, and diabetes. Among stroke-related factors, length of stay of index stroke admission
was associated with increased readmission rate, followed by bowel incontinence, feeding tube, and urinary catheter. Conclusion.
Although risk factors and common causes of readmission were identified, none of the previous studies investigated causes and their
sequence of readmissions among high-impact stroke users.
1. Introduction
Stroke is one of the leading causes of morbidity andmortality
in the world and the cost of management of stroke has vastly
increased [1]. Most cases occur in people over the age of 65
years [2]. Approximately 80% of stroke cases are ischaemic in
nature, while the remainder are haemorrhagic [2]. Ischaemic
stroke (IS) is caused by a thromboembolic event in the
diseased artery resulting in acute blockage of the blood supply
to a region of the brain [2, 3]. Haemorrhagic stroke results
from rupture of a blood vessel or an abnormal vascular
structure [3]. This results in bleed in the brain. Subarachnoid
haemorrhage (SAH) is a subtype of haemorrhagic stroke that
is caused by bleeding on the surface of the brain, whereas in
intracerebral haemorrhage (ICH) bleeding occurs within the
brain tissue [4].
Various aspects of stroke management have evolved in
recent years [5]. Regional programs took a range of initiatives
to improve outcomes of stroke, including quicker paramedic
services to reach specialised stroke units early, rapid scan-
ning, increased use of thrombolysis within 4 hours of stroke
onset, and early rehabilitative program [2]. Previous clinical
trials and observational studies have not thoroughly analysed
the impact of new management strategies on outcomes of
stroke due to small patient cohorts and limited follow-up [6].
Hospital administrative data provides an alternative
method to evaluate outcomes of stroke [7]. The initial care
of stroke is hospital-based and most complications require
hospital reviews, admissions, and regular follow-up [6]. This
piece of information is recorded in hospital administrative
data and can be used to analyse readmissions [7]. Hospital
administrative data has been used in recent years to study
various aspects of stroke care [8]. It has the advantage of
providing a large cohort of patients, which can be followed
up for a long period because the data are generally linked by
individual identifier [8].
Hospitalisation and readmission are commonly available
information in hospital administrative data [9]. The World
Hindawi Publishing Corporation
Stroke Research and Treatment
Volume 2016, Article ID 9325368, 11 pages
http://dx.doi.org/10.1155/2016/9325368
2 Stroke Research and Treatment
Table 1: MESH terms used for literature search.
1 exp stroke/
2 Brain Ischemia/ or Stroke/ or ischaemic stroke.mp. or Cerebrovascular Disorders/ or Cerebral Infarction/
3 haemorrhagic stroke.mp.
4 Intracranial Hemorrhages/ or hemorrhagic stroke.mp.
5 ischemic stroke.mp.
6 exp hospitalization/
7 hospitalisation.mp.
8 Patient Readmission/ or readmission.mp.
9 readmission rate.mp.
10 Treatment Outcome/ or complication rate.mp.
11 6 or 7 or 8 or 9 or 10
12 1 or 2 or 3 or 4 or 5
13 11 and 12
Health Organisation suggested that the use of imaging,
thrombolysis, length of stay in hospital, and duration of
rehabilitation vary in different regions giving rise to variation
in mortality and readmission rate of stroke patients [10]. The
Patient Protection and Affordable Care Act (PPACA) in US
penalizes healthcare for increased RR but it is still not clear
what proportion of these readmissions are preventable [11].
The patient population has been categorised into two groups,
“high-impact” and “low-impact” users, based on the use of
healthcare resources [12]. High-impact users form a small
subgroup of patients who utilise the majority of healthcare
resources with repeated and persistent readmissions to hos-
pital [12].The evidence on factors and causes of readmissions
associated with high-impact users is scanty [9]. Moreover,
most of the readmissions are measured within 30 days of a
stroke event; hence, it is still to be discovered if the reasons for
long-term readmissions are common in different regions [13].
The aim of the study was to review the evidence on common
causes and patterns of short- and long-term readmissions
in stroke patients by conducting a systematic review of
studies using hospital administrative data. Common risk
factors associatedwith changes in readmission rates were also
examined.
2. Methods
The literature search was conducted from 15 February to 15
March 2016. The following literature databases were used:
Embase (1947–2016), Medline (1946–2016), and Web of Sci-
ence (1950–2016). Various MESH terms were used to identify
studies that evaluated outcomes of stroke patients (Table 1).
Alternative spellings for the terms were also included in the
search, such as “hemorrhage”, “haemorrhagic”, “ischemia”,
and “ischemic”. All the terms were combined with option
“OR” to include all search titles. All the subheadings were
included in the search. Further studies were identified
through cross-referencing of studies reviewed initially. Once,
various search terms were explored for stroke and readmis-
sion, they were combined with “AND” to include relevant
studies for review.
The following inclusion criteria were used:
(1) Studies looking at an adult patient population over
the age of 18 years diagnosed with nontraumatic
ischaemic or haemorrhagic stroke.
(2) Studies utilising hospital administrative data to assess
clinical outcomes following an event of stroke.
(3) Studies evaluating readmission of stroke patients due
to any cause.
The following exclusion criteria were used:
(1) Studies that reported stroke as a complication or
adverse event of another disease.
(2) Studies that reported cost-effectiveness rather than
clinical outcomes of stroke.
The search strategy for the selection of studies was based
on PRISMA protocol, which is primarily used to conduct
systematic reviews [14] (Figure 1). Further studies were
identified through the cross-referencing of initial stud-
ies reviewed. Two independent researchers, EB and AR,
reviewed the selected studies separately. Basic demographics
were obtained from each study included in the review. Year
of study, place of data collection, administrative databases
used, and aims and objectives of studies were recorded. Infor-
mation on methodology of each study was collected, such
as number of patients, types of stroke, kinds of readmission
rate, and follow-up period. Significant effect of risk factor
associated with change in readmission rate was measured as
odds ratio (OR), hazards ratio (HR), percentage change, or
relative risk (RR), with the confidence interval (CI) of 95%.
Ratios and risks adjusted for other confounding factors and
having significant impact on RR, 𝑝 < 0.05, were mentioned
in the review.
The Newcastle-Ottawa scale was used to assess bias in
the studies [15]. The scale uses a star ranking system based
on 3 major criteria: selection of participants, comparability,
and definition of outcome. A maximum of 8 stars can be
obtained by a study and would indicate a low degree of
bias. The scale is validated and recommended by Cochrane
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7115879 titles were identified
after initial terms search
14959 titles were recognised
after combination of terms and
exclusion of duplicate terms
224 titles were included for
abstract review after screening
of titles
78 full articles were reviewed
based on reading of their
abstracts
24 studies were identified to
be included in the review
7100919 titles were deleted
based on combination of 
search/mesh terms
14734 titles were excluded, as
they explicitly did not relate to
topic
116 studies were excluded
following review of abstracts
54 studies were excluded 
(did not meet inclusion criteria)
Figure 1: PRISMA diagram for the selection of studies included in
the review.
reviewmethodological guidelines for nonrandomised cohort
studies.
3. Results
There were a total of 24 studies included in the review
(Table 2). Eleven studies selected patients over the age of 65
[9, 13, 16–21], while the rest of the studies included all adult
patients. The majority of the studies only included patients
with ischaemic stroke. Few studies assessed outcomes in both
haemorrhagic and ischaemic stroke patients [4, 6, 18, 21–
25]. Eleven studies had high rating on the Newcastle-Ottawa
scoring system, 6 and above, suggesting a low risk of bias
associated with them [9, 13, 16–19, 22, 23, 25–28].These stud-
ies benefitted from large population-based cohort of stroke
patients, selection of a comparison group from the same
population, clearly defined outcome measure, comparison
of readmission rates between groups, and adequate follow-
up. Other studies with low scoring lacked a well-demarcated
control group, comparison of outcomes between groups, and
complete long-term follow-up.
3.1. Causes of Readmission. Four studies evaluated causes of
readmissions in stroke patients (Table 3). Common disease-
related groups for all-cause 30-day readmission in all types
of stroke patients were as follows: kidney and urinary tract
infections, simple pneumonia and pleurisy, heart failure and
shock, oesophagitis, gastritis, and other gastrointestinal dis-
orders, and, lastly, nutritional and other metabolic disorders
[21]. Common causes of 30-day unplanned readmissions
in ischaemic stroke patients were recurrent stroke (33%),
infections (septicaemia, aspiration pneumonia, pneumonia,
and urinary tract infections, collectively 14.5%), and cardiac
conditions (dysrhythmia, congestive heart failure, chest pain,
and acute myocardial infarction, collectively 10.4%) [11].
Common causes of all-cause 1-year readmissions for haem-
orrhagic and ischaemic stroke were recurrent stroke (26.3%),
infections (15.1%), accidents (9.5%), cardiopulmonary disease
(9.1%), cancer (3.5%), diabetes (2.2%), and other causes
(32.7%) [6]. In a study with a 5-year follow-up, the causes
of readmissions were as follows: pneumonia and respiratory
causes (8.6%), acute MI (5%), recurrent stroke (4.9%), gas-
trointestinal disorders (3.9%), congestive heart failure (3%),
other vascular diagnoses (2.9%), cardiothoracic procedures
(1.8%), psychiatric disorders (0.4%), hip fractures (0.2%), and
other diagnoses (21.8%) [9].
3.2. Factors Associated with the Change in the Readmission
Rate. Based on the net number of studies mentioning risk
factors impacting the readmission rate, common patient-
related risk factors associated with increased readmission
rate were age and history of coronary heart disease, heart
failure, renal disease, respiratory disease, peripheral arterial
disease, and diabetes (Table 4). Among stroke-related factors,
length of stay of index stroke admission was associated with
increased readmission rate, followed by bowel incontinence,
feeding tube, and urinary catheter.
Increased age, past medical history of vascular condi-
tions, heart failure, and renal disease were common risk
factors associated with the increase in the readmission rate
of various types based on studies that reported factors with
positive impact on readmission rate (Table 5).
Certain risk factors were found to be associated with
reduction in the readmission rate. All-cause 30-day readmis-
sion rate was significantly reduced by early decision of not
to resuscitate [29], social engagement [29], and higher use of
occupational therapy [11]. All-cause 90-day readmission rate
was significantly reduced by the use of inpatient rehabilitation
[24] and all-cause 1-year readmission rate was declined by the
persistent use of antiplatelet therapy [26].
Care of patients in the certified stroke centres [18] and
critical access hospitals [19] had no impact on readmission
rate. Two studies evaluated 1-year all-cause readmission rate
and 1-year readmission for fractures in stroke patients but did
not assess risk factors associated with change in readmission
rate [30, 31].
4. Discussion
This review was based on 24 studies that identified various
risk factors and causes of readmission. Prominent causes of
readmissions were recurrent stroke, respiratory and urinary
infections, acute cardiac conditions, and diabetes. In gen-
eral, elderly patients with a background of cardiovascular
conditions had increased short- and long-term readmission
rate. None of the studies evaluated factors and causes of
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Table 4: Risk factors and their impact on all-cause, preventable, and cerebrovascular readmission rate.
Risk factors Number of studies with
positive association
Number of studies with
negative association
Number of studies with no
significant association
Patient-related factors
Age 8 1
Coronary heart disease 4
Female gender 4 3
Heart failure 4 1
Renal disease 4
Diabetes 3 1
Peripheral arterial disease 3
Respiratory disease 3
Atrial fibrillation 2 1
Cancer 2 1
Comorbidity score 2
Depression 2 1
Prior hospitalisations 2
Socioeconomic status 2
Alcohol misuse 1
Anaemia 1
C difficile infection 1
Dementia 1 2
Hypertension 1 3
Hypotension 1
Immobility 1
Marital status, married 1
Non-Caucasian ethnicity 1 1 1
Parkinson’s disease 1
Pressure ulcers 1
TIA 1
Valvular heart disease/prosthetic valves 1
Do not resuscitate order 1
Hypercholesterolemia 1
Obesity 1
Previous stroke 1
Rheumatic disorders 1
Smoking 1
Stroke-related factors
Length of stay 3
Feeding tube 1
Bowel incontinence 1
Urinary catheter 1
Bladder incontinence 1
Signs and symptoms score 1
Aphasia 1
Hemiparesis 1
Aspiration pneumonia 1
Hospital care related factors
District hospitals with critical care access 1 1
Stroke Research and Treatment 7
Table 4: Continued.
Risk factors Number of studies withpositive association
Number of studies with
negative association
Number of studies with no
significant association
Treatment by neurologist 1 1
Discharge to nursing home 1 1
Specialised stroke centres 1
Inpatient rehabilitation facility 1 1
Use of ICU/HDU 2
Endarterectomy 1
Stenting 1
Gastrostomy 1
Intubation 1
Dialysis 1
Occupational therapy 1
Thrombolysis 2
Urgent scanning 1
readmission in different subgroups of stroke patients, in par-
ticular high-impact users. Studies used different definitions
of readmission rate, which made it difficult to compare the
data and perform meta-analysis.
The review has focused on studies using administrative
data to analyse significant factors and causes of readmission
at population level. This may help health policy makers to
develop accurate prediction models and management plans
at regional level for patients at high risk of readmissions.
Previous clinical studies have assessed similar risk factors
but they had the disadvantage of limited number of patients
and a shorter follow-up period [7, 32]. Calculation of
cause-specific readmission rates required a larger sample of
patients, possibly with the use of hospital administrative data
[25, 33].
The long-term pattern of readmissions in different sub-
groups of stroke patients could not be deduced from the
review. Most of the studies calculated readmission rate with a
follow-up of less than one year [13, 16, 27, 28]. Studies with
long-term follow-up period merely focused on risk factors
associated with higher readmission rate [4, 31]. A minority
of studies evaluated common causes of readmission with
crude cross-sectional analysis of whole population. No effort
was made to categorise patients into subgroups based on
rate of readmission and cumulative LOS. This would have
been particularly helpful to identify patients with a high-
impact use of hospital care or those who have the potential
to become high impact [12, 34]. None of the studies inves-
tigated the sequence of hospitalisations in stroke patients.
Although common causes of readmission were identified,
further investigation is needed to find out the timing of
occurrence of causes of readmission. If there is a difference in
the timing of occurrence of causes of readmission or pattern
of hospital care use in subgroups of stroke patients is still
uncertain.This could provide vital information as it has been
shown that subgroups of pneumonia patients had variable
prognosis and time to recovery based on timing of occurrence
of complications [35].
The readmission rate was shown to provide relevant and
detailed information on the outcome of stroke when the
metric was cause-specific, risk-standardised, and assessed
unplanned readmissions for preventable causes [6, 9]. Cause-
specific readmission rates were mostly calculated for pre-
ventable complications, for example, sepsis, recurrent stroke,
and fracture [25, 26, 31]. Recurrence rate was a cause-specific
readmission rate that measured rate of another stroke event
after first stroke. In another study, time to first recurrent
stroke was also analysed [26]. The identification of specific
causes of readmission based on ICD discharge coding has
been shown to be validated and highly sensitive [32].
Measurement of 30-day all-cause readmission to assess
the quality of care was recommended by the Affordable Care
Act and the Agency of Healthcare Research and Quality
(AHRQ) in the US [26]. Hospitals with higher 30-day
readmission rates were penalized, with the aim of improving
the quality of care by reducing readmission rate. However, a
significant proportion of patients after stroke get readmitted
for planned procedures, on-going care follow-up, and reha-
bilitation [11, 29]. The measurement of cause-specific 30-day
readmission rate would be better instead, because it can be
used to calculate readmission rates due to preventable causes.
For example, compliance with antiplatelet therapy was shown
to reduce readmission rates for recurrent stroke [29].
Studies have used readmission rate as an outcome mea-
sure to assess morbidity in the patients after they had stroke
[4, 13, 17–19, 22, 23, 27, 30]. It has been used along with
other outcome metrics, such as length of stay, discharge
destination, andmortality rate.Theyhave performed separate
analysis to evaluate factors impacting the mortality rate of
the patients. They mainly focused on assessing annual trends
and the impact of various factors on the overall outcome
and prognosis of the stroke patients. Hence, factors were
recognized which impacted both readmission and mortality
rate or just one of them. Since hospitals are penalized for
higher readmission rate in some regions, certain studies have
only focused on measuring factors associated with higher
8 Stroke Research and Treatment
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readmission rate and avoidable causes of readmission [8, 11,
21, 26, 29].
The review had a few limitations. The review only
included those studies that used administrative data. The
data is collected over a large patient population increasing
its generalizability. Most of the studies evaluating causes of
readmissions have used administrative data. Other studies
using local observational or clinical data had a small patient
sample and mainly focused on assessing risk factors associ-
ated with the change in the readmission rate. By reviewing
studies using administrative data, we have tried to reduce
heterogeneity between the studies. However, the selection
of stroke patients is based on coding system used by the
researchers, which can introduce selection bias and impair its
validity. The use of diagnostic coding is prone to errors when
used to select cohort of the stroke patients and identifying
causes of readmissions. This can lead to bias in the effect
measure estimates, such as odds ratio and relative risk.
Very few studies evaluated long-term outcomes of stroke.
Some studies used the same database; common databases
used were Medicare, Medicaid, and Veterans Affairs (VA)
administrative data [9, 13, 16, 17, 23, 26, 32]. Readmission
rates with multiple definitions were used in the studies,
making it difficult for homogenous international comparison.
The studies analysing hospital administrative data are prone
to selection bias as specific codes are used to identify the
cohort of patients from retrospectively collected data and
the comparison groups are not randomised [32]. Coding
errors have been associated with the use of administrative
data [12]. This may affect precise identification of stroke
patients and calculation of incidence of complications. In
some studies, comparison groups were not matched for
confounding factors [4, 9]. Similarly, readmission rates were
not risk-standardised to tackle a common problem with the
use of administrative data, that is, patient case-mix [26, 33].
Common causes of readmission were identified, but
further research is required to find out the sequence and
pattern of causes of long-term readmission in stroke patients.
Previous studies have evaluated risk factors and causes of
readmission for stroke population as a whole [12]. However,
it will be more beneficial to investigate risk factors and
pattern of readmission in subgroups of patients based on their
readmission rate [12].
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